Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.26%-352.79K | 1.67%-640.47K | 28.64%-581.87K | 44.13%-2.63M | 41.55%-836K | 80.67%-322.9K | -8.29%-651.35K | 18.24%-815.37K | -33.44%-4.7M | -2.47%-1.43M |
| Net income from continuing operations | 72.72%-453.17K | 26.44%-653.75K | 24.92%-647.26K | 60.48%-4.58M | 81.46%-1.17M | -6.91%-1.66M | 48.00%-888.69K | 57.44%-862.12K | -53.98%-11.59M | -148.50%-6.3M |
| Operating gains losses | 171.97%742 | 99.92%-364 | -97.96%1.79K | -154.23%-165.92K | -22.50%213.18K | -105.22%-1.03K | -68,572.50%-465.61K | 739.16%87.55K | 722.44%305.92K | 645.92%275.07K |
| Depreciation and amortization | -91.34%11.94K | -69.09%12.93K | -88.52%15.4K | -34.84%268.23K | -128.98%-45.6K | 55.97%137.78K | -49.48%41.84K | 61.44%134.22K | 151.97%411.64K | 126.15%157.36K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.27M | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | -165.82%-103.47K | ---- | ---- | ---- | ---- | --157.21K | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 67.31%-28.32K | 91.73%-6.51K |
| Remuneration paid in stock | --0 | --0 | --0 | -44.90%1.01M | 205.34%27.26K | 753.29%919.1K | -97.65%11.21K | -95.87%51.09K | -46.97%1.83M | -97.63%8.93K |
| Other non cashItems | -221.64%-18.93K | -106.52%-24.38K | 31.45%-21.08K | 111.02%51.03K | 8.73%-307.76K | 135.90%15.56K | 998.85%373.99K | 25.25%-30.76K | -151.57%-463.27K | ---337.19K |
| Change In working capital | -60.07%106.63K | -90.91%25.09K | 135.47%69.29K | 251.74%896.32K | 184.30%548.74K | 197.70%267.01K | -33.38%275.91K | -142.45%-195.35K | -58.93%-590.68K | -768.03%-650.96K |
| -Change in receivables | -41.26%109.14K | -96.74%25.92K | 116.18%103.75K | 210.52%650.05K | 176.74%311.29K | 133.38%185.82K | 1,144.13%794.25K | -244.62%-641.31K | -49.45%-588.17K | -6.42%-405.63K |
| -Change in prepaid assets | -66.48%27.67K | -112.62%-26.64K | -96.58%5.39K | 384.77%548.36K | 505.87%97.01K | 126.82%82.56K | 2,233.56%211.16K | 74.65%157.62K | -51.03%-192.56K | 108.12%16.01K |
| -Change in payables and accrued expense | -2,108.41%-30.19K | 103.54%25.82K | -113.82%-39.85K | -258.96%-302.09K | 153.74%140.44K | 96.97%-1.37K | -251.61%-729.5K | 1,788.31%288.35K | 27.20%190.04K | -151.91%-261.35K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.26%-352.79K | 1.67%-640.47K | 28.64%-581.87K | 44.13%-2.63M | 41.55%-836K | 80.67%-322.9K | -8.29%-651.35K | 18.24%-815.37K | -33.44%-4.7M | -2.47%-1.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 124.82%230.33K | 92.96%-208.88K | 98.30%-53.6K | 50.92%-8.28M | 9.71%-1.24M | 84.01%-927.99K | 28.97%-2.97M | 42.97%-3.15M | 5.48%-16.88M | 63.66%-1.37M |
| Capital expenditure reported | ---- | ---- | 92.60%-215.08K | 24.92%-7.09M | 73.10%-477.19K | ---- | ---- | ---2.9M | 6.47%-9.44M | ---1.77M |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --8.09K | -75.96%3.39M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---3.31M | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | -119.36%-55.35K | -156.54%-55.35K | --0 | ---- | ---- | --285.89K | --97.9K |
| Net other investing changes | 865.14%290.54K | 102.52%3.86K | 165.75%161.49K | 74.17%-1.14M | -409.39%-706.48K | 97.22%-37.97K | ---153K | ---245.59K | 43.03%-4.43M | --228.35K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 124.82%230.33K | 92.96%-208.88K | 98.30%-53.6K | 50.92%-8.28M | 9.71%-1.24M | 84.01%-927.99K | 28.97%-2.97M | 42.97%-3.15M | 5.48%-16.88M | 63.66%-1.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 204.16K | 0 | 0 | 0 | 206.33%21.43M | -99.80%10.96K | ||||
| Net common stock issuance | --204.16K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 290.19%21.15M | -99.80%10.96K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -82.17%280.92K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --204.16K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 206.33%21.43M | -99.80%10.96K |
| Net cash flow | ||||||||||
| Beginning cash position | -90.09%396.5K | -93.29%546.21K | -90.21%1.18M | -1.13%12.09M | -78.36%3.22M | -82.34%4M | 41.35%8.15M | -1.13%12.09M | -54.05%12.23M | 23.81%14.87M |
| Current changes in cash | 106.53%81.7K | 95.86%-149.97K | 83.98%-635.47K | -7,260.79%-10.91M | 25.67%-2.08M | 83.94%-1.25M | -121.41%-3.62M | 38.68%-3.97M | 98.97%-148.23K | -1,386.79%-2.79M |
| Effect of exchange rate changes | -121.79%-101.79K | 100.05%258 | -109.33%-1.79K | -79.60%2.11K | 282.13%39.46K | --467.13K | ---523.63K | --19.15K | --10.33K | --10.33K |
| End cash Position | -88.31%376.41K | -90.09%396.5K | -93.29%546.21K | -90.21%1.18M | -90.21%1.18M | -78.36%3.22M | -82.34%4M | 41.35%8.15M | -1.13%12.09M | -1.13%12.09M |
| Free cash from | 65.95%-413K | 75.38%-853.21K | 78.58%-796.95K | 31.30%-9.71M | -858.59%-1.31M | 80.37%-1.21M | -115.26%-3.47M | 42.95%-3.72M | -3.86%-14.14M | -93.33%173.11K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.